Article
Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies.
Acta oncologica (Stockholm, Sweden) - 1 Jul 2016
Franconieri Fréderic, Martin-Silva Nicolas, de Boysson Hubert, Galateau-Salle Françoise, Emile Jean-François, Bienvenu Boris, Aouba Achille
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.